Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Lung Cancer

Screening scans 'could cut lung cancer deaths’

Introducing lung screening for people at high risk of lung cancer could reduce deaths from the disease, according to new unpublished research.

Scientists discover first step towards finding a new, targeted lung cancer treatment

Scientists have identified a key molecular player in a subtype of lung cancer, which could lead to a new way to tackle the disease.

Cancer Research UK tests first of its kind vaccine to treat lung cancer

A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.

Choice of lung cancer treatment could be affecting survival

Variations in lung cancer treatment may be limiting survival in England, according to a new study.

New Year’s Honours 2018: Professor Caroline Dive, CBE, and her career in lung cancer research

Our researcher, Professor Caroline Dive, has received a CBE in this year's New Year's Honours list. We spoke to her about her outstanding career.

Tackling ‘undruggable’ genes in lung and pancreatic cancers is this researcher’s life

Two important cancer genes cooperate to make lung cancers more aggressive in mice, according to new research.

From cancer evolution to targeting faulty genetics – our new fellows

Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time.

Cancer patients diagnosed at an earlier stage are more likely to have surgery than chemotherapy

A world-first data report could help us understand whether cancer patients are getting the most appropriate treatments for them.

News digest – repurposed drugs, HIV, bisphosphonates and… a prostate cancer ‘cure’?

From this week’s cancer news we look at how HIV research could offer clues about lung cancer and bust headlines about a radiotherapy ‘cure’ for prostate cancer.

Cancer blood tests and learning from HIV – our latest Pioneer Awards

Drawing similarities between how the immune system reacts to lung cancer and HIV could uncover potential new drug targets.

Pages